Join to View Full Profile
1101 E Marshall StRichmond, VA 23298
Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012- University of Rochester Medical CenterResidency, Neurology, 2007 - 2011
University of Arizona College of MedicineClass of 2007
University of ArizonaBS, Molecular and Cellular Biology and Psychology, 2002
Certifications & Licensure
VA State Medical License 2018 - 2026
NC State Medical License 2020 - 2022
UT State Medical License 2013 - 2020
NY State Medical License 2011 - 2014
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- Rasch-analysis of Clinical Severity in FSHD Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- A toolkit for new facioscapulohumeral muscular dystrophy trial sites.Joost Kools, Lawrence Korngut, Janet Petrillo Ballantyne, Irene Roozen, Ria de Haas
Journal of Neuromuscular Diseases. 2025-12-26 - Expert Consensus on Genetic Diagnostic Approaches for Patients With Limb-Girdle Muscular Dystrophy.Volker Straub, Amanda R Clause, Sandra Donkervoort, Peter B Kang, Chamindra G Laverty
Neurology. 2025-11-25 - 2 citationsMyotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives.Lisa Rahm, Melissa A Hale, Renée H L Raaijmakers, Alexandra Marrero Quiñones, Tejal Patki
Nature Reviews. Neurology. 2025-11-01
Journal Articles
- The Impact of Congenital and Childhood Myotonic Dystrophy on Quality of Life: A Qualitative Study of Associated SymptomsJohnson NE, Luebbe E, Eastwood E, Chin N, Moxley RT 3rd, Heatwole CR, J Child Neurol, 1/1/2013
- New insights about the incidence, multisystem manifestations, and care of patients with congenital myotonic dystrophyHilbert JE, Johnson NE, Moxley RT 3rd, J Pediatr, 1/1/2013
- Myotonia congenita in a patient who presented with diplopia and ptosis [Letter to the editor]Odrzywolski K, Johnson NE, Twydell PT, Muscle Nerve, 1/1/2013
Press Mentions
On TrialApril 21st, 2025- AB-1003 Trial for LGMD Proceeds After Positive RecommendationMarch 11th, 2025
- AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second CohortMarch 7th, 2025
Grant Support
- Preparing for Therapeutics across the Spectrum of Myotonic DystrophyVIRGINIA COMMONWEALTH UNIVERSITY2025–2030
- Preparing for Therapeutics across the Spectrum of Myotonic DystrophyVIRGINIA COMMONWEALTH UNIVERSITY2025–2030
- Identifying the RNA Splicing and Gene Expression Changes that Cause Congenital Myotonic Dystrophy (Renewal)VIRGINIA COMMONWEALTH UNIVERSITY2018–2029
- Trial Readiness and Endpoint Assessment in LGMDR1 (TREATing-LGMDR1)VIRGINIA COMMONWEALTH UNIVERSITY2023–2028
- Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal)VIRGINIA COMMONWEALTH UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
